Ketone bodies and brain glutamate and GABA metabolism

Developmental Neuroscience

Volumn 20, Issue 4-5, 1998, Pages 358-364

  Daikhin, Yevgeny ^a   Yudkoff, Marc ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Brain metabolism; Epilepsy; GABA; Glutamate; Ketogenic diet; Mass spectrometry

Indexed keywords

3 HYDROXYBUTYRIC ACID; 4 AMINOBUTYRIC ACID; ACETOACETIC ACID; ACETYL COENZYME A; ASPARTATE AMINOTRANSFERASE; ASPARTIC ACID; CITRATE SYNTHASE; CITRIC ACID; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; GLUTAMINE; KETONE BODY; OXALOACETIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ASTROCYTE; BRAIN; BRAIN METABOLISM; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; FOREBRAIN; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNAPTOSOME; TRANSAMINATION;

ANIMALS; ASPARTATE AMINOTRANSFERASES; ASPARTIC ACID; ASTROCYTES; BRAIN; CELLS, CULTURED; CITRATE (SI)-SYNTHASE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; KETONE BODIES; MICE; NEUROGLIA; NEURONS; SYNAPTOSOMES;

EID: 0031731468     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017331     Document Type: Conference Paper

References (64)

1. Aicardi J: Clinical approach to the management of intractable epilepsy. Dev Med Child Neurol 1988;30:429-440.
2. Freeman JM, Kelly MT, Freeman JB: The Epilepsy Diet Treatment: An Introduction to the Ketogenic Diet. New York, Demos, 1994.
3. Huttenlocher PR: Ketonemia and seizures: Metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res 1976;10:536-540.
4. DeVivo DC, Leckie MP, Ferrendelli JS, McDougal DB Jr: Chronic ketosis and cerebral metabolism. Ann Neurol 1978;3:331-337.
5. Kinsman SL, Vining EPG, Quaskey SA, et al: Efficacy of the ketogenic diet for intractable seizure disorders: Review of 58 cases. Epilepsia 1992;33:1132-1136.
6. Livingstone S, Pauli LL, Pruce I: Ketogenic diet in the treatment of childhood epilepsy. Dev Med Child Neurol 1977;19:833-834.
7. Prasad AN, Stafstrom CF, Holmes GL: Alternative epilepsy therapies: The ketogenic diet, immunoglobulins, and steroids. Epilepsia 1996;37(suppl 1):81-95.
8. Resnick TJ, Gennaro P, Duchowny MS, Gilman J, Alvarez LA, Jayakar P, Dean P: Epilepsy and the ketogenic diet. Int Pediatr 1997;12: 102-105.
9. Uhlemann ER, Neims AH: Anticonvulsant properties of the ketogenic diet in mice. J Pharmacol Ther 1972;180:231-238.
10. Erecinska M, Nelson D, Daikhin Y, Yudkoff M: Regulation of GABA level in rat brain synaptosomes: Fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies. J Neurochem 1996;67: 2325-2334.
11. Yudkoff M, Daikhin Y, Nissim I, Grunstein R, Nissim I: Effect of ketone bodies on astrocyte amino acid metabolism. J Neurochem 1997; 69:682-692.
12. DeDeyn PP, Marescau B, MacDonald RL: Epilepsy and the GABA hypothesis: A brief review and some samples. Acta Neurol Belg 1990;90: 65-81.
13. Olsen RW, Avoli M: GABA and epileptogenesis. Epilepsia 1997;38:399-407.
14. Bradford HF: Glutamate, GABA and epilepsy. Prog Neurobiol 1995;47:477-511.
15. Gjedde A, Crone C: Induction processes in blood-brain transfer of ketone bodies during starvation. Am J Physiol 1975;229:1165-1169.
16. Pollay M, Stevens FA: Starvation-induced changes in transport of ketone bodies across the blood-brain barrier. J Neurosci Res 1980;5: 163-172.
17. Hasselbalch SG, Knudsen GM, Jakobsen J, Pinborg Hageman L, Holm S, Paulson OB: Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans. Am J Physiol 1995;268:E1161-E1166.
18. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF: Brain metabolism during fasting. J Clin Invest 1967;46:1589-1595.
19. Tildon JT, McKenna MC, Stevenson JH: Differential effects of serum protein(s) on substrate oxidation by isolated synaptosomes and cultured rat brain astrocytes. Dev Neurosci 1994;15:226-232.
20. Booth RFG, Clark JB: A rapid method for the preparation of relatively pure, metabolically competent synaptosomes from rat brain. Biochem J 1978;176:365-370.
21. Edmond J, Robbins RA, Berstron JD, Cole RA, deVellis J: Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res 1987; 18:551-556.
22. 14C]butyrate by dissociated cells from rat brain. Am J Physiol 1988;255:C133-C139.
23. Tildon JT, McKenna MC, Stevenson JH Jr: Transport of 3-hydroxybutyrate by cultured rat brain astrocytes. Neurochem Res 1994;19: 1237-1242.
24. McKenna MC, Tildon JT, Stevenson JH, Boatright R, HuangS: Regulation of energy metabolism in synaptic terminals and cultured rat brain astrocytes: Differences revealed using aminooxyacetate. Dev Neurosci 1994;15:320-329.
25. Robinson AM, Williamson DH: Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev 1980;60: 143-187.
26. Thurston JH, Hauhart RE, Schiro JA: Beta-hydroxybutyrate reverses insulin-induced hypoglycemic coma in suckling-weanling mice despite low blood and brain glucose levels. Metab Brain Dis 1986;1:63-82.
27. Yudkoff M, Nelson D, Daikhin Y, Erecinska M: Tricarboxylic acid cycle in rat brain synaptosomes. Fluxes and interactions with aspartate aminotransferase and malate/aspartate shuttle. J Biol Chem 1994;269:27414-27420.
28. Mason GF, Gruetter R, Rothman DL, Behar KL, Shulman RG, Novotny EJ: Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J Cereb Blood Flow Metab 1995;15:12-25.
29. Fitzpatrick SM, Cooper AJL, Duffy TE: Use of β-methylene-DL-aspartate to assess the role of aspartate aminotransferase in cerebral oxidative metabolism. J Neurochem 1983;41:1370-1383.
30. Rosenblatt J, Chinkes D, Wolfe M, Wolfe RR: Stable isotope tracer analysis by GC-MS, including quantification of isotopomer effects. Am J Physiol 1992;263:E584-E596.
31. Norenberg MD, Martinez-Hernandez A: Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 1979;161: 303-310.
32. Westergaard N, Sonnewald U, Unsgard G, Peng L, Hertz L, Schousboe A: Uptake, release, and metabolism of citrate in neurons and astrocytes in primary cultures. J Neurochem 1994; 62:1727-1733.
33. Sato K, Kashiwaya Y, Keon CA, Tsuchiya N, King MT, Radda GK, Chance B, Clarke K, Veech RL: Insulin, ketone bodies and mitochondrial energy transduction. FASEB J 1995; 9:651-658.
34. Russell RR III, Taegtmeyer H: Coenzyme A sequestration in rat hearts oxidizing ketone bodies. J Clin Invest 1992;89:968-973.
35. Lemieux G, Pichette C, Vinay P, Gougoux A: Cellular mechanisms of the antiammoniagenic effect of ketone bodies in the dog. Am J Physiol 1980;239:F420-F426.
36. Wu J-Y, Roberts E: Properties of brain L-glutamate decarboxylase: Inhibition studies. J Neurochem 1974;23:759-767.
37. Porter TG, Martin DL: Evidence for feedback regulation of glutamate decarboxylase by γ-aminobutyric acid. J Neurochem 1984;43: 1464-1467.
38. Ratnakumari L, Murthy CRK: Activities of pyruvate dehydrogenase, enzymes of citric acid cycle, and aminotransferases in the subcellular fractions of cerebral cortex in normal and hyperammonemic rats. Neurochem Res 1989;14: 221-228.
39. + and adenosine triphosphate in isolated brain synaptosomes. J Gen Physiol 1990;95:591-616.
40. Storm-Mathisen J, Leknes AK, Bore AT, Vaaland JL, Edminson P, Haug FM, Ottersen OP: First visualization of glutamate and GABA in neurones by immunocytochemistry. Nature 1983;301:517-520.
41. Storm-Mathisen J, Ottersen OP: Antibodies against amino acid neurotransmitters; in Paunula P, Paivarinta H, Soinila S (eds): Neurohistochemistry: Modern Methods and Applications. New York, Liss, 1986, pp 107-136.
42. Patel AJ, Balazs R, Richter D: Contribution of the GABA bypath to glucose oxidation, and the development of compartmentation in the brain. Nature 1970;226:1160-1161.
43. Patel AJ, Johnson AL, Balazs R: Metabolic compartmentation of glutamate associated with the formation of γ-aminobutyrate. J Neurochem 1974;23:1271-1279.
44. +-evoked release of transmitter amino acids investigated by microdialysis. J Neurochem 1989;52:1823-1829.
45. Battaglioli G, Martin DL: Stimulation of synaptosomal γ-aminobutyric acid synthesis by glutamate and glutamine. J Neurochem 1990; 54:1179-1187.
46. Kaufman DL, Houser CR, Tobin AJ: Two forms of the γ-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem 1991;56:720-723.
47. 13C]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl-GABA). Neurochem Res 1996;21:1031-1041.
48. Wu J-Y: Purification, characterization and kinetic studies of GAD and GABA-T from mouse brain; in Roberts E, Chase TN, Tower DB (eds): GABA in Nervous System Function. New York, Raven Press, 1976, pp 7-55.
49. Porter TG, Martin DL: Stability and activation of glutamate apodecarboxylase from pig brain. J Neurochem 1988;51:1886-1891.
50. Losher W, Swark WS: Evidence for impaired GABAergic activity in the substantia nigra of amygdaloid kindled rats. Brain Res 1985;339: 146-150.
51. Lasley SM, Yan QS: Diminished potassium-stimulated GABA release in vivo in genetically epilepsy-prone rats. Neurosci Lett 1994;175: 145-148.
52. Gould EM, Curto KA, Craig CR, Fleming WW, Taylor DA: The role of GABA-A receptors in the subsensitivity of Purkinje neurons to GABA in genetic epilepsy-prone rats. Brain Res 1995;698:62-68.
53. Hovanics GE, DeLorey TM, Firestone LL, Quinlan JJ, Handforth A, Harrison NL, Krasowski MD, Rick CE, Korpi ER, Makela R, Brilliant MH, Hagiwara N, Ferguson C, Snyder K, Olsen RW: Mice devoid of gamma-aminobutyrate type A receptor beta-3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci USA 1997;94: 4143-4148.
54. White HS: Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs. Epilepsia 1997; 38(suppl 1):9-17.
55. Meldrum BS: Update on the mechanism of action of antiepileptic drugs. Epilepsia 1996; 37(suppl 6):4-11.
56. Petroff OA, Rothman D, Behar KL, Mattson RH: Low brain GABA level is associated with poor seizure control. Ann Neurol 1996;40:908-911.
57. 1H-NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 1993;90:5662-5666.
58. Flavin HJ, Wieraszko A, Seyfried TN: Enhanced aspartate release from hippocampal slices of epileptic (E1) mice. J Neurochem 1991;56:1007-1010.
59. Millan MH, Chapman AG, Meldrum BS: Extracellular amino acid levels in hippocampus during pilocarpine-induced seizures. Epilepsy Res 1993;14:139-148.
60. Do KO, Klancnik J, Gahwiler BH, et al: Release of EAA: Animal studies and epileptic foci studies in humans; in Meldrum BS, Moroni F, Simon RP (eds): Excitatory Amino Acids. New York, Raven Press, 1991, pp 677-685.
61. Carlson H, Ronne-Engstrum E, Ungerstedt U, Hillered L: Seizure-related elevations of extracellular amino acids in human focal epilepsy. Neurosci Lett 1992;140:30-32.
62. Fleck MW, Henze DA, Barrionuevo G, Palmer AM: Aspartate and glutamate mediate excitatory synaptic transmissiqn in area CA1 of the hippocampus. J Neurosci 1993;13:3944-3955.
63. Martin D, Bustos GA, Bowe MA, Bray SD, Nadler JV: Autoreceptor regulation of glutamate and aspartate release from slices of the hippocampal CA1 area. J Neurochem 1991;56: 1647-1655.
64. Raiteri M, Marchi M, Costi A, Volpe G: Endogenous aspartate release in the rat hippocampus inhibited by M2 'cardiac' muscarinic receptors. Eur J Pharmacol 1990;177:181-187.